fda semaglutide ban compounding news alerts health care providers, compounders and patients of dosing errors associated with compounded injectable Compounded Semaglutide & Tirzepatide 2025:

In rodent studies, GLP-1s caused thyroid tumors, including thyroid cancer

Self-administering research-grade peptides without medical supervision introduces multiple layers of risk: Working with a qualified medical team eliminates these risks and ensures that your peptide therapy is aligned with your broader health and fitness goals

doi:10.1016/j.beem.2015.04.008

Archived from the original on 2016-02-10

This randomized, double-blind trial enrolled adults with obesity or those who were overweight with at least one related health condition

Some studies using highly specific radioligand assays found even lower rates or failed to detect receptors at all in normal human thyroid tissue